health
-
Moderna’s New mNEXSPIKE COVID-19 Vaccine Wins FDA Approval After Phase 3 Trial
The Moderna COVID-19 vaccine, also known as Spikevax, has been a crucial tool in the fight against COVID-19, a disease caused by…
-
Diabetes Drugs Show Promise in Treating Addiction and Cravings
A class of medications originally developed for diabetes is now being investigated for a completely different purpose: treating addiction. GLP-1 receptor agonists,…
-
West Texas Measles Outbreak Reaches 146 Cases After a Child’s Death
As of February 28, 2025, Texas health officials have recorded 146 confirmed measles infections spread across nine counties, with twenty of those…
-
Texas Measles Cases Rise to 146 With 20 Hospitalized and One Child Dead
A significant surge in measles cases has been reported in Texas, United States, with the number of confirmed cases reaching 146 as…
-
Measles Kills Unvaccinated Texas Child, First US Death in Nearly a Decade
Lubbock, Texas, February 26, 2025 — cybernewschronicle.com — For the first time in a quarter-century, measles has killed someone in the United…
-
Lubbock Doctors Describe Measles Outbreak as Unvaccinated Child’s Death Is Confirmed
LUBBOCK, Texas — A child who was not vaccinated against measles has died at a hospital in Lubbock, marking the first death…
-
Cholera Kills 58 and Sickens 1,293 in Sudan’s Kosti Over Three Days
A cholera outbreak in Kosti, White Nile State, has claimed the lives of 58 people and affected 1,293 others, according to Sudanese…
-
P&O Iona Passengers Fall Ill With Suspected Norovirus Off Belgium
A norovirus outbreak aboard the MS Iona cruise ship in Belgium has created a critical situation for hundreds of passengers, particularly those…
-
Norovirus Outbreak Strikes MS Iona Cruise Ship in Belgium
In Belgium, a norovirus outbreak has unfolded on the MS Iona cruise ship, impacting a considerable number of passengers. Dr. Maria Rodriguez,…
-
FDA Approves Vertex’s Journavx, the First New Class of Pain Medicine in Over 20 Years
Vertex Pharmaceuticals is awaiting a regulatory decision on suzetrigine, a non-opioid analgesic designed for moderate to severe acute pain. The drug, which…
-
AHS Position Statement Makes CGRP Migraine Drugs a First-Line Preventive Option
America, March 12, 2024 — cyberinktimes.com — For millions of Americans who live with migraines, the standard advice has long been the…
-
E. coli Outbreak Hits 75 Cases in McDonald’s Quarter Pounders
The E. coli outbreak tied to McDonald’s Quarter Pounder hamburgers now stands at 75 confirmed cases as of October 25, 2024. That…
-
FDA Approves Genentech’s Inavolisib for PIK3CA-Mutated Advanced Breast Cancer
On 15 October 2024, the U.S. Food and Drug Administration granted market authorization to Inavolisib, a novel therapy from Genentech, a Roche…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
Rwanda Reports First Marburg Virus Outbreak
The World Health Organization (WHO) has been informed of the first-ever outbreak of Marburg virus disease (MVD) in Rwanda, as reported on…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
FDA Approves Lazertinib With Amivantamab as First-Line Treatment for EGFR Lung Cancer
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
Gabon Confirms First Mpox Case in Man Who Returned From Uganda
Health authorities in Gabon announced on August 23 that a man who arrived by air from Uganda has tested positive for mpox.…
-
FDA Approves Voranigo, a Daily Pill That Delays Progression of Low-Grade Glioma
Each year, about 1,500 Americans receive a diagnosis of grade 2 glioma, a slowly progressing yet aggressive brain tumor. Until now, treatment…
-
MAHA Push Is Changing How Americans Snack, NIQ Data Shows
WASHINGTON, D.C. — The slogan “Make America Healthy Again” is not new. Its roots stretch back decades through the public-health work of…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
FDA Approves Yuhan’s Lazertinib, First Korean-Developed Cancer Drug to Win Approval
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
Deli Meat Outbreak in US Claims Lives and Sparks Safety Concerns
A listeriosis outbreak tied to Boar’s Head Provision Company deli meats has led to at least 10 fatalities and 60 hospitalizations across…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992